265 related articles for article (PubMed ID: 38540261)
21. Diffuse large B-cell lymphoma variants: an update.
Sukswai N; Lyapichev K; Khoury JD; Medeiros LJ
Pathology; 2020 Jan; 52(1):53-67. PubMed ID: 31735345
[TBL] [Abstract][Full Text] [Related]
22. Clinicopathological analysis of primary intestinal diffuse large B-cell lymphoma: Prognostic evaluation of CD5, PD-L1, and Epstein-Barr virus on tumor cells.
Ishikawa E; Kato S; Shimada K; Tanaka T; Suzuki Y; Satou A; Kohno K; Sakakibara A; Yamamura T; Nakamura M; Miyahara R; Goto H; Nakamura S; Hirooka Y
Cancer Med; 2018 Dec; 7(12):6051-6063. PubMed ID: 30449068
[TBL] [Abstract][Full Text] [Related]
23. Epstein-Barr virus-associated B-cell lymphoproliferative disorders and lymphomas: a review.
Marques-Piubelli ML; Salas YI; Pachas C; Becker-Hecker R; Vega F; Miranda RN
Pathology; 2020 Jan; 52(1):40-52. PubMed ID: 31706670
[TBL] [Abstract][Full Text] [Related]
24. A population-based study of 135 lymphomas after solid organ transplantation: The role of Epstein-Barr virus, hepatitis C and diffuse large B-cell lymphoma subtype in clinical presentation and survival.
Kinch A; Baecklund E; Backlin C; Ekman T; Molin D; Tufveson G; Fernberg P; Sundström C; Pauksens K; Enblad G
Acta Oncol; 2014 May; 53(5):669-79. PubMed ID: 24164103
[TBL] [Abstract][Full Text] [Related]
25. Epstein-Barr Virus-Positive Not Otherwise Specified (EBV+ NOS) Lymphoma Presentation of Primary Bone Tumor Underlying a Pathological Fracture.
Tippabhatla A; Atalay RT; Gyftopoulos A; Ayele GM; Michael MB
Cureus; 2022 Jun; 14(6):e26340. PubMed ID: 35903563
[TBL] [Abstract][Full Text] [Related]
26. Splenic large B-cell lymphoma in patients with hepatitis C virus infection.
Takeshita M; Sakai H; Okamura S; Oshiro Y; Higaki K; Nakashima O; Uike N; Yamamoto I; Kinjo M; Matsubara F
Hum Pathol; 2005 Aug; 36(8):878-85. PubMed ID: 16112004
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus seroprevalence in patients with diffuse large B cell lymphoma and Hodgkin's lymphoma.
Mert D; Merdin A; Ceken S; Dal MS; Ertek M; Altuntas F
J Cancer Res Ther; 2021; 17(4):951-955. PubMed ID: 34528547
[TBL] [Abstract][Full Text] [Related]
28. An analysis of MYC and EBV in diffuse large B-cell lymphomas associated with angioimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma not otherwise specified.
Hoffmann JC; Chisholm KM; Cherry A; Chen J; Arber DA; Natkunam Y; Warnke RA; Ohgami RS
Hum Pathol; 2016 Feb; 48():9-17. PubMed ID: 26772393
[TBL] [Abstract][Full Text] [Related]
29. Bacterial Infection and Non-Hodgkin B-Cell Lymphoma: Interactions between Pathogen, Host and the Tumor Environment.
Biernat MM; Wróbel T
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298992
[TBL] [Abstract][Full Text] [Related]
30. Epstein-Barr virus (EBV) positive diffuse large B cell lymphoma of the elderly-experience of a single center from Turkey.
Ozsan N; Cagirgan S; Saydam G; Gunes A; Hekimgil M
Pathol Res Pract; 2013 Aug; 209(8):471-8. PubMed ID: 23726928
[TBL] [Abstract][Full Text] [Related]
31. Epstein-Barr Virus-Positive Diffuse Large B cell Lymphoma in the Experience of a Tertiary Medical Center in Poland.
Ziarkiewicz M; Wołosz D; Dzieciątkowski T; Wilczek E; Dwilewicz-Trojaczek J; Jędrzejczak WW; Gierej B; Ziarkiewicz-Wróblewska B
Arch Immunol Ther Exp (Warsz); 2016 Apr; 64(2):159-69. PubMed ID: 26084760
[TBL] [Abstract][Full Text] [Related]
32. [Prevalence and clinico-pathological characteristics in patients with Epstein-Barr virus-positive diffuse large B-cell lymphoma in a high complexity hospital in Cali, Columbia].
Amaya D; Moreno JC; Calvache N; Castro A; Pérez B; Silva N
Rev Esp Patol; 2019; 52(3):139-146. PubMed ID: 31213254
[TBL] [Abstract][Full Text] [Related]
33. Seroprevalence of Epstein-Barr virus, hepatitis B virus, hepatitis C virus, and human immunodeficiency virus among patients with non-Hodgkin's lymphoma at the Yaounde General Hospital, Cameroon.
Bikoï JN; Ndedi EDFM; Okobalemba EA; Mbaga DS; Mikangue CAM; Membangbi AE; Nguiffo EM; Essindi JO; Mondinde GI; Essama SHR
Pan Afr Med J; 2022; 42():58. PubMed ID: 35949454
[TBL] [Abstract][Full Text] [Related]
34. Frequent expression of PD-L1 in BLS-type diffuse large B-cell lymphoma: implications for aggressiveness and immunotherapy.
Yang CF; Yu YT; Wang SH; Chen YP; Chen TY; Hsu CY; Medeiros LJ; Chang KC
Pathology; 2024 Apr; 56(3):367-373. PubMed ID: 38290893
[TBL] [Abstract][Full Text] [Related]
35. EBV-Positive Lymphoproliferations of B- T- and NK-Cell Derivation in Non-Immunocompromised Hosts.
Dojcinov SD; Fend F; Quintanilla-Martinez L
Pathogens; 2018 Mar; 7(1):. PubMed ID: 29518976
[TBL] [Abstract][Full Text] [Related]
36. Epstein-Barr virus-negative diffuse large B-cell lymphoma hosts intra- and peritumoral B-cells with activated Epstein-Barr virus.
Stuhlmann-Laeisz C; Szczepanowski M; Borchert A; Brüggemann M; Klapper W
Virchows Arch; 2015 Jan; 466(1):85-92. PubMed ID: 25339301
[TBL] [Abstract][Full Text] [Related]
37. Epstein-Barr Virus and the Pathogenesis of Diffuse Large B-Cell Lymphoma.
Ross AM; Leahy CI; Neylon F; Steigerova J; Flodr P; Navratilova M; Urbankova H; Vrzalikova K; Mundo L; Lazzi S; Leoncini L; Pugh M; Murray PG
Life (Basel); 2023 Feb; 13(2):. PubMed ID: 36836878
[TBL] [Abstract][Full Text] [Related]
38. The biology and treatment of Epstein-Barr virus-positive diffuse large B cell lymphoma, NOS.
Li JW; Deng C; Zhou XY; Deng R
Heliyon; 2024 Jan; 10(1):e23921. PubMed ID: 38234917
[TBL] [Abstract][Full Text] [Related]
39. Reappraisal of Epstein-Barr virus (EBV) in diffuse large B-cell lymphoma (DLBCL): comparative analysis between EBV-positive and EBV-negative DLBCL with EBV-positive bystander cells.
Ohashi A; Kato S; Okamoto A; Inaguma Y; Satou A; Tsuzuki T; Emi N; Okamoto M; Nakamura S
Histopathology; 2017 Jul; 71(1):89-97. PubMed ID: 28231401
[TBL] [Abstract][Full Text] [Related]
40. CircEAF2 counteracts Epstein-Barr virus-positive diffuse large B-cell lymphoma progression via miR-BART19-3p/APC/β-catenin axis.
Zhao CX; Yan ZX; Wen JJ; Fu D; Xu PP; Wang L; Cheng S; Hu JD; Zhao WL
Mol Cancer; 2021 Dec; 20(1):153. PubMed ID: 34852843
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]